1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsAutoimmune Diseases Statistical and Clinical Coordinating Center (AD-SCCC) (U01 Clinical Trial Not Allowed) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). Seeks applications for a coordinating center to provide support for clinical trials in autoimmune diseases and related areas.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Autoimmune Diseases Statistical and Clinical Coordinating Center (AD-SCCC) (U01 Clinical Trial Not Allowed) Autoimmune Diseases Statistical and Clinical Coordinating Center (AD-SCCC) (U01 Clinical Trial Not Allowed) Agency: National Institutes of Health Assistance Listings: 93. 855 -- Allergy and Infectious Diseases Research Last Updated: June 25, 2026 View version history on Grants.
gov The purpose of this notice of funding opportunity (NOFO) is to solicit applications for an Autoimmune Diseases Statistical and Clinical Coordinating Center (AD-SCCC).
The AD-SCCC will provide clinical study and clinical trial development, management, repository management, manuscript production, study archiving and biostatistical support for ongoing and future clinical trials in the areas of autoimmune diseases, mucosal immunology, and inborn errors of immunity while maintaining and supporting all relevant regulatory requirements.
The AD-SCCC may also collaborate with and assist the National Institute of Allergy and Infectious Diseases (NIAID) Clinical Site Monitoring Center (CSMC), and other NIAID resources. style="margin-left:2.
3pt;">The AD-SCCC will support clinical study and trial programs including the Autoimmunity Centers of Excellence and the Immune Tolerance Network, as well other NIAID-supported clinical trials or study activities, including Investigator-Initiated Clinical Trials.
Federally recognized Native American tribal governments City or township governments Special district governments Public and Indian housing authorities Other Native American tribal organizations Nonprofits non-higher education with 501(c)(3) Nonprofits non-higher education without 501(c)(3) For-profit organizations other than small businesses Private institutions of higher education Public and state institutions of higher education Independent school districts Refer to Section III.
Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed. Grantor contact information No documents are currently available. Link to additional information Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: Nonprofits, including faith-based and community-based organizations, and regional organizations. Confirm the full requirements in the official notice before applying.
Autoimmune Diseases Statistical and Clinical Coordinating Center (AD-SCCC) (U01 Clinical Trial Not Allowed) is funded by National Institute of Allergy and Infectious Diseases (NIAID). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleThe ReVAMPP network funds vaccine and monoclonal antibody research across five virus families. Here is who won, what the prototype-pathogen strategy means, and how to position for the next round.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read article